banner
7Z-Trifostigmanoside I
Inquiry

Cat. No.: X22-05-ZQ702

7Z-Trifostigmanoside I

Synonym: 1018898-17-3; 7-Z-Trifostigmanoside I; 7Z-Trifostigmanoside I; (4S)-4-[(E,3S)-3-[(2R,3R,4S,5S,6R)-3-[(2S,3R,4R)-3,4-Dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-1-enyl]-4-Hydroxy-3,5,5-trimethylcyclohex-2-en-1-one

  • CAS Number: 1018898-17-3
  • Compound CID: 134715241
img
Product Size
5 mg; 10 mg; 20 mg
Price
Datasheet
MSDS
Properties
Description
7Z-Trifostigmanoside I is isolated from the whole plants of Polygala hongkongensis. This product is widely used in research in the fields of pharmaceuticals, cosmetics and health products.
Molecular Weight
518.56
Molecular Formula
C24H38O12
Source
Polygala hongkongensis
Part Used
Whole plants
Form
Powder
Purity
≥98%, determined by HPLC.
Identity
Confirmed by MS and NMR.
Applications
7Z-Trifostigmanoside I is widely used in research in the fields of pharmaceuticals, cosmetics and health products.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0